EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+23.15%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$481M
AUM Growth
+$83.7M
(+21%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 95.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $186M | 38.79% |
1,450,000
| – | – |
|
|
ENTL
2
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $84.6M | 17.6% |
3,813,197
| – | – |
|
|
RVNC
3
DELISTED
Revance Therapeutics, Inc.
RVNC
| $74.4M | 15.49% |
4,592,047
| – | – |
|
|
CORI
4
DELISTED
Corium International, Inc.
CORI
| $52.7M | 10.96% |
9,353,304
| – | – |
|
5
Axogen
AXGN
$770M
| $43.9M | 9.13% |
4,861,111
| – | – |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $22.9M | 4.76% |
125,747
| – | – |
|
7
MediciNova
MNOV
$61.3M
| $8.77M | 1.82% |
1,170,370
| – | – |
|
|
ACUR
8
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $3.13M | 0.65% |
1,956,397
| – | – |
|
9
Ligand Pharmaceuticals
LGND
$3.24B
| $2.4M | 0.5% |
52,727
| – | – |
|
10
Gyre Therapeutics
GYRE
$689M
| $1.45M | 0.3% |
10,483
| – | – |
|